Rasagiline in Parkinson's disease.
Youdim
Moussa B H
MB
D000818:Animals; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007189:Indans / Q000008:administration & dosage*; D051379:Mice; D008996:Monoamine Oxidase Inhibitors / Q000008:administration & dosage; D018696:Neuroprotective Agents / Q000008:administration & dosage*; D010300:Parkinson Disease / Q000188:drug therapy*; D020794:Receptor Protein-Tyrosine Kinases / Q000187:drug effects / Q000378:metabolism
D007189:Indans; D008996:Monoamine Oxidase Inhibitors; D018696:Neuroprotective Agents; C031967:rasagiline; D020794:Receptor Protein-Tyrosine Kinases